{"id":"https://openalex.org/W2139669271","doi":"https://doi.org/10.1002/mds.22450","title":"Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease","display_name":"Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease","alternate_titles":[],"publication_year":2009,"publication_date":"2009-02-27","ids":{"openalex":"https://openalex.org/W2139669271","doi":"https://doi.org/10.1002/mds.22450","mag":"2139669271","pmid":"https://pubmed.ncbi.nlm.nih.gov/19253412"},"language":"en","primary_location":{"id":"doi:10.1002/mds.22450","doi":"https://doi.org/10.1002/mds.22450","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.22450","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139669271"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056517132","display_name":"David Devos","orcid":"https://orcid.org/0000-0002-2417-799X","observed_orcids":["https://orcid.org/0000-0002-2417-799X"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210101212","display_name":"H\u00f4pital Roger Salengro","ror":"https://ror.org/0165ax130","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"David Devos","raw_affiliation_strings":["Department of Neurology, EA2683 IFR114 IMPRT, H\u00f4pital R. Salengro, CHU Lille, France. d-devos@chru-lille.fr","Department of Neurology, EA2683 IFR114 IMPRT, CHU Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, EA2683 IFR114 IMPRT, H\u00f4pital R. Salengro, CHU Lille, France. d-devos@chru-lille.fr","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"]},{"raw_affiliation_string":"Department of Neurology, EA2683 IFR114 IMPRT, CHU Lille, France","institution_ids":["https://openalex.org/I3018718406"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the French DUODOPA Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the French DUODOPA Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5056517132"],"corresponding_institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210101212"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":12.2731,"has_fulltext":false,"cited_by_count":206,"citation_normalized_percentile":{"value":0.99163636,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"24","issue":"7","first_page":"993","last_page":"1000"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.014299999922513962,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10863","display_name":"Voice and Speech Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3616","display_name":"Speech and Hearing"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-parkinson-s-disease","display_name":"advanced Parkinson's disease","score":0.859000027179718},{"id":"https://openalex.org/keywords/motor-complications","display_name":"motor complications","score":0.9440000057220459},{"id":"https://openalex.org/keywords/motor-fluctuations","display_name":"motor fluctuations","score":0.7310000061988831},{"id":"https://openalex.org/keywords/last-line-therapy","display_name":"last-line therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.48399999737739563},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6690000295639038},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.5450000166893005},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.640999972820282},{"id":"https://openalex.org/keywords/technical-challenges","display_name":"technical challenges","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.9338647127151489},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7927890419960022},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6210638284683228},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5414820313453674},{"id":"https://openalex.org/C2776494729","wikidata":"https://www.wikidata.org/wiki/Q1848900","display_name":"Contraindication","level":3,"score":0.5261789560317993},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5021991729736328},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.468544602394104},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37483227252960205},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.32942795753479004},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.32899773120880127},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3233673870563507},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3208111524581909},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003704","descriptor_name":"Dementia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003704","descriptor_name":"Dementia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004386","descriptor_name":"Duodenum","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006212","descriptor_name":"Hallucinations","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006212","descriptor_name":"Hallucinations","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020233","descriptor_name":"Gait Disorders, Neurologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020233","descriptor_name":"Gait Disorders, Neurologic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D026684","descriptor_name":"Personal Autonomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1002/mds.22450","doi":"https://doi.org/10.1002/mds.22450","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.22450","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},{"id":"pmid:19253412","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19253412","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement disorders : official journal of the Movement Disorder Society","raw_type":"Evaluation Study"},{"id":"pmh:oai:HAL:inserm-00410554v1","doi":null,"is_oa":false,"landing_page_url":"https://inserm.hal.science/inserm-00410554","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Movement Disorders, 2009, 24 (7), pp.993-1000. &#x27E8;10.1002/mds.22450&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.600.8271","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.600.8271","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.movementdisorders.org/monthly_edition/2009/06/md_article.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1966681262","https://openalex.org/W1969018656","https://openalex.org/W1969522203","https://openalex.org/W1985133850","https://openalex.org/W1996813582","https://openalex.org/W1997214637","https://openalex.org/W2003670766","https://openalex.org/W2011418698","https://openalex.org/W2021048089","https://openalex.org/W2032251866","https://openalex.org/W2052426694","https://openalex.org/W2061469930","https://openalex.org/W2071294003","https://openalex.org/W2095270577","https://openalex.org/W2121642596","https://openalex.org/W2132881915","https://openalex.org/W2137566057","https://openalex.org/W2150028758","https://openalex.org/W2433431146"],"related_works":["https://openalex.org/W1991538916","https://openalex.org/W1969522203","https://openalex.org/W1988680456","https://openalex.org/W2084242280","https://openalex.org/W2061469930","https://openalex.org/W2136200053","https://openalex.org/W2060898487","https://openalex.org/W2079887732","https://openalex.org/W2083623374"],"abstract_inverted_index":{"The":[0,35,82],"studies":[1],"of":[2,5,11,37,47,55,92,121,128,134,149,162],"duodenal":[3,32,56,69],"infusion":[4,58,71,116,178],"a":[6,78],"levodopa":[7,33,57,70,115,177],"on":[8,18],"small":[9],"groups":[10],"parkinsonian":[12],"patients":[13,66],"have":[14],"reported":[15,155],"beneficial":[16],"effects":[17],"motor":[19,124,159,187],"complications.":[20],"However,":[21],"little":[22],"is":[23,40],"known":[24],"about":[25],"the":[26,44,48,64,118,129,150],"patient":[27],"profile":[28],"and":[29,50,53,108,140,164,195],"indications":[30],"for":[31,123,137,186],"infusion.":[34],"purpose":[36],"this":[38],"study":[39],"to":[41,132,180],"exhaustively":[42],"investigate":[43],"clinical":[45],"characteristics":[46],"population":[49],"indication,":[51],"efficacy":[52],"tolerability":[54],"in":[59,77,126,158,189],"natural":[60],"care":[61],"settings.":[62],"Of":[63,152],"102":[65],"treated":[67],"with":[68,88],"since":[72],"2003,":[73],"91":[74],"were":[75,96,110,167,174],"enrolled":[76],"multicentre":[79],"retrospective":[80],"study.":[81],"mean":[83],"age":[84],"was":[85,117,145],"72.7":[86],"years,":[87],"average":[89],"disease":[90],"duration":[91],"17":[93],"years.":[94],"Patients":[95],"at":[97],"advanced":[98],"stage:":[99],"91%":[100],"had":[101,105],"gait":[102],"disorders,":[103],"65%":[104],"visual":[106],"hallucinations,":[107],"50%":[109],"demented":[111],"(MMSE:":[112],"23).":[113],"Duodenal":[114,176],"last":[119],"line":[120],"treatment":[122,144],"complications":[125,188],"98%":[127],"patients,":[130],"due":[131],"failure":[133],"or":[135],"contraindication":[136],"apomorphine":[138],"pump":[139],"neurosurgical":[141],"treatments.":[142],"Long-term":[143],"observed":[146],"by":[147],"73%":[148],"population.":[151],"these,":[153],">90%":[154],"an":[156,182],"improvement":[157],"fluctuations,":[160],"quality":[161],"life,":[163],"autonomy.":[165],"There":[166],"few":[168],"severe":[169],"adverse":[170],"events.":[171],"Technical":[172],"problems":[173],"commonplace.":[175],"seems":[179],"be":[181,199],"effective":[183],"last-line":[184],"therapy":[185],"Parkinson's":[190],"disease.":[191],"Hence,":[192],"technical":[193],"improvements":[194],"earlier":[196],"introduction":[197],"should":[198],"considered.":[200]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139669271","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":30},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
